WHO ICTRP trial

A Clinical Study to evaluate the Efficacy and Safety of TLPL/AY/04/2008 as an…

CTRI/2009/091/000605 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2009/091/000605
Public title A Clinical Study to evaluate the Efficacy and Safety of TLPL/AY/04/2008 as an adjuvant to Oral Hypoglycemic agents (OHAs) in Type 2 Diabetic Patients.
Scientific title A Randomized, Double blind, Placebo controlled, Phase 2 Clinical Study to evaluate the Efficacy and Safety of TLPL/AY/04/2008 as an Add-on therapy with Oral Hypoglycemic agents (OHA) in Type 2 Diabetic Patients.
Primary sponsor Tulip Lab Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India;India;India;India
Conditions Health Condition 1: null- Type II Diabetes mellitus
Interventions Intervention1: TLPL/AY/04/2008: Each Film coated tablet contains Madhunashini extract (Gymnema sylvestre R.Br), Asana extract (Pterocarpus marcupium Roxb.), Amalaki extract (Emblica officinalis Gaertn), Mamijva extract (Enicostemma…
Registration date Jan 18, 2011
Target size 80
Secondary IDs TLPL/AY/04/2008/CT-1, Version 2, Dated 24.07.2009
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations